Lonza | LONN - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Akzo Nobel EUR 1.62B 66M 2025-12
Alcon AG USD 1.58B 80M 2026-03
Almirall EUR 337.77M 14.83M 2025-12
AstraZeneca USD 7.56B 1.85B 2026-03
BASF EUR 2.67B 811M 2025-12
Bayer EUR 6.67B 774M 2025-12
Beiersdorf EUR 1.2B 33M 2025-12
Covestro EUR 648M 44M 2025-12
Demant DKK 1.33B 188M 2025-12
Fresenius EUR 1.31B 81M 2025-12
Fresenius Medical Care EUR 1.24B 343.37M 2026-03
Geberit CHF 403.6M 4.1M 2025-03
Genmab DKK 1.72B 46M 2025-12
Givaudan CHF 603M 3M 2024-06
GlaxoSmithKline GBP 3.44B 292M 2026-03
GN Store Nord DKK 1.12B 352M 2025-12
Hikma Pharmaceutical USD 236M 48M 2025-06
Johnson Matthey GBP 542M 49M 2024-06
Merck EUR 2.33B 77M 2025-12
Novartis USD 6.88B 4.56B 2026-03
Philips EUR 2.79B 882M 2025-12
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
Sika AG CHF 1.87B 1.18B 2022-12
Solvay EUR 486M 50M 2026-03
UCB EUR 1.57B 1.14B 2024-12